New, rapid CRISPR/Cas9 method identifies key genes in zebrafish spinal cord regeneration

International task force determines current Parkinson’s disease subtyping may not fit all patients
29 April 2021
Study: ISCHEMIA trial represents small fraction of patients undergoing intervention
29 April 2021

New, rapid CRISPR/Cas9 method identifies key genes in zebrafish spinal cord regeneration

A new, rapid screening approach uses CRISPR/Cas9 technology to identify immune system-related genes that play a crucial role in repairing zebrafish spinal cord injuries. Marcus Keatinge and Themistoklis Tsarouchas of the University of Edinburgh, U.K., and colleagues present these findings in the open-access journal PLOS Genetics.

Comments are closed.